Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Seeks Dedicated Meta-Analysis Team As Part Of PDUFA V User Fee Funding

Executive Summary

FDA wants to create a meta-analysis team to conduct its own studies with funding from the next round of application user fees.
Advertisement

Related Content

PDUFA V Agreement Set In Four Areas, But Broad FDA/Industry Talks Continue
PDUFA V Agreement Set In Four Areas, But Broad FDA/Industry Talks Continue
Avandia Shows FDA Discomfort With Meta-Analyses, Observational Studies In Decision-Making
FDA, EMA Decisions On Avandia Reflect The Power Of REMS
FDA, EMA Decisions On Avandia Reflect The Power Of REMS
Meta-Analyses Will Get Separate Guidance Documents From FDA And IoM
FDA Clears Drugs With Post-Market Safety Questions Faster Than It Re-labels

Topics

Advertisement
UsernamePublicRestriction

Register

PS052956

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel